Pricing Log in Create free account
Saturday 17 October 2026 Export SYK’s income statement to Excel — free account

Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.42%, EPS grew 43.1%, free cash flow grew 14.1% and total debt fell 9.88%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.

294.66 1.43 +0.49%
Market cap
$112.5B
P/E
30.3×
Fwd P/E
24.1×
Dividend yield
1.19%
F-score
5/9
Altman Z
4.81
Beneish M
−2.62
Dividend safety
82/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Stryker Corporation (SYK) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Stryker Corporation (SYK) trades at a EV/EBITDA of 18.4×. Over the past ten years it has ranged from 14.6× (January 2016) to 37.9× (April 2021); the current reading is higher than 14% of that period. That is above the Medical Devices industry median of 11.5× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 24.0× (22.18%)
FY2024 30.9× 23.99%
FY2023 24.9× (8.25%)
FY2022 27.1× (12.06%)
FY2021 30.9× (9.06%)
FY2020 33.9× 39.06%
FY2019 24.4× 22.76%
FY2018 19.9× (7.98%)
FY2017 21.6× 21.92%
FY2016 17.7× 14.56%

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 19.6× (11.67%)
Mar 2026 22.2× (7.76%)
Dec 2025 24.0× (25.32%)
Sep 2025 32.2× (8.25%)
42 more quarters

Against its own ten years

Low 14.6× High 37.9×
Ten-year median 24.9×
Current reading's percentile 14

EV/EBITDA against peers

Company EV/EBITDA
PHG Koninklijke Philips N.V. compare 8.8×
GEHC GE HealthCare Technologies Inc. compare 12.3×
BSX Boston Scientific Corporation compare 13.9×
STE STERIS plc compare 14.2×
MDT Medtronic PLC compare 14.5×
SYK Stryker Corporation 18.4×
ABT Abbott Laboratories compare 19.4×
DXCM DexCom, Inc. compare 23.5×
EW Edwards Lifesciences Corporation compare 29.0×
Medical Devices industry median 11.5×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on SYK